M. Fesneau, E. Champeaux-orange, and C. Hennequin, Anal cancer, Cancer Radiother J Soc Francaise Radiother Oncol, vol.14, issue.1, pp.120-126, 2010.

G. Renehan and A. , Current treatment of anal squamous cell carcinoma, Hematol Oncol Clin North Am. déc, vol.26, issue.6, p.131550, 2012.

G. Nilsson, P. J. Aschele, C. Goh, V. Peiffert, D. Cervantes et al., Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up, Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol, vol.40, issue.10, p.116576, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01799935

L. G. Johnson, M. M. Madeleine, L. M. Newcomer, S. M. Schwartz, and J. R. Daling, Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, Cancer. 15 juill, vol.101, issue.2, p.2818, 1973.

A. E. Grulich, I. M. Poynten, D. A. Machalek, J. F. Templeton, D. J. Hillman et al., The epidemiology of anal cancer, Sex Health. déc, vol.9, issue.6, p.5048, 2012.

L. Abramowitz, N. Mathieu, F. Roudot-thoraval, N. Lemarchand, P. Bauer et al., Epidermoid anal cancer prognosis comparison among HIV+ and HIV? patients, Aliment Pharmacol Ther. août, vol.30, issue.4, p.41421, 2009.

N. D. Nigro, V. K. Vaitkevicius, T. Buroker, G. T. Bradley, and B. Considine, Combined therapy for cancer of the anal canal, Dis Colon Rectum. avr, vol.24, issue.2, p.735, 1981.

N. D. Nigro, H. G. Seydel, B. Considine, V. K. Vaitkevicius, L. Leichman et al., Combined preoperative radiation and chemotherapy for squamous cell carcinoma of the anal canal, Cancer. 15 mai, vol.51, issue.10, p.18269, 1983.

N. D. Nigro, An evaluation of combined therapy for squamous cell cancer of the anal canal, Dis Colon Rectum. déc, vol.27, issue.12, p.7636, 1984.

N. D. Nigro, V. K. Vaitkevicius, and B. Considine, Dynamic management of squamous cell cancer of the anal canal, Invest New Drugs. avr, vol.7, issue.1, p.839, 1989.

J. A. Ajani, K. A. Winter, L. L. Gunderson, J. Pedersen, A. B. Benson et al., Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial, JAMA. 23 avr, vol.299, issue.16, p.191421, 2008.

V. Vendrely, C. Lemanski, E. François, E. Barbier, B. Hamed et al., OC-0284: First results of the French cohort ANABASE : treatment and outcome in non-metastatic anal cancer, Radiother Oncol. avr, vol.127, p.146, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01962677

S. Everitt, T. Kron, T. Leong, M. Schneider-kolsky, and M. M. Manus, Geographic miss in radiation oncology: Have we missed the boat, J Med Imaging Radiat Oncol, vol.53, issue.5, p.5069, 2009.

J. L. Wright, S. M. Patil, L. Temple, B. D. Minsky, L. B. Saltz et al., Squamous Cell Carcinoma of the Anal Canal: Patterns and Predictors of Failure and Implications for Intensity-Modulated Radiation Treatment Planning, Int J Radiat Oncol, vol.78, issue.4, p.106472, 2010.

P. Das, S. Bhatia, C. Eng, J. A. Ajani, J. M. Skibber et al., Predictors and Patterns of Recurrence After Definitive Chemoradiation for Anal Cancer, Int J Radiat Oncol. juill, vol.68, issue.3, p.794800, 2007.
DOI : 10.1016/j.ijrobp.2006.12.052

L. A. Dawson, Y. Anzai, L. Marsh, M. K. Martel, A. Paulino et al., Patterns of localregional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer, Int J Radiat Oncol Biol Phys, vol.46, issue.5, pp.1117-1126, 2000.
DOI : 10.1016/s0360-3016(99)00550-7

G. O. Schoenfeld, R. J. Amdur, C. G. Morris, J. G. Li, R. W. Hinerman et al., Patterns of Failure and Toxicity after Intensity-Modulated Radiotherapy for Head and Neck Cancer, Int J Radiat Oncol. juin, vol.71, issue.2, p.37785, 2008.
DOI : 10.1016/j.ijrobp.2007.10.010

A. Mohamed, D. I. Rosenthal, M. J. Awan, A. S. Garden, E. Kocak-uzel et al., Methodology for analysis and reporting patterns of failure in the Era of IMRT: head and neck cancer applications, Radiat Oncol. déc, vol.11, issue.1, 2016.

S. Johansen, M. H. Norman, E. Dale, C. D. Amdal, T. Furre et al., Patterns of localregional recurrence after conformal and intensity-modulated radiotherapy for head and neck cancer, Radiat Oncol. déc, vol.12, issue.1, 2017.

A. Jemal, E. P. Simard, C. Dorell, A. Noone, L. E. Markowitz et al., Estimation de l'incidence et de la mortalité par cancer en France métropolitaine entre 1980 et 2012-invs.santepubliquefrance.fr 21, JNCI J Natl Cancer Inst. 6 févr, vol.105, issue.3, p.175201, 1975.

S. Grabar, D. Costagliola, and A. Bouvier, Épidémiologie du cancer de l'anus, Cancéro Dig, issue.4, 2011.

C. Hennequin and L. Quero, Radiothérapie du cancer du rectum et du canal anal. 1 janv, 2014.

P. Maingon, . Tg, and J. F. Bosset, Cancer du canal anal

L. Moureau-zabotto, V. Vendrely, L. Abramowitz, C. Borg, E. Francois et al., Anal cancer: French Intergroup Clinical Practice Guidelines for diagnosis, treatment and follow-up, vol.49, p.83140, 2017.

J. Fléjou, Anatomie pathologique des cancers du canal anal, Cancéro Dig, issue.4, 2011.

B. G. Czito and C. G. Willett, Current management of anal canal cancer, Curr Oncol Rep. mai, vol.11, issue.3, p.18692, 2009.

P. F. Engstrom, J. P. Arnoletti, A. B. Benson, J. D. Berlin, J. M. Berry et al., NCCN clinical practice guidelines in oncology. Anal carcinoma, J Natl Compr Cancer Netw JNCCN. janv, vol.8, issue.1, p.10620, 2010.

B. Sischy, R. Doggett, J. M. Krall, D. G. Taylor, W. T. Sause et al., Definitive Irradiation and Chemotherapy for Radiosensitization in Management of Anal Carcinoma: Interim Report on Radiation Therapy Oncology Group Study No. 8314, JNCI J Natl Cancer Inst. 7 juin, vol.81, issue.11, p.8507, 1989.

W. R. Meeker, B. J. Sickle-santanello, G. Philpott, D. Kenady, K. I. Bland et al., Combined chemotherapy, radiation, and surgery for epithelial cancer of the anal canal, Cancer. 1 févr, vol.57, issue.3, p.5259, 1986.

R. A. Michaelson, G. B. Magill, S. H. Quan, R. H. Leaming, M. Nikrui et al., Preoperative chemotherapy and radiation therapy in the management of anal epidermoid carcinoma, Cancer. 1 févr, vol.51, issue.3, p.3905, 1983.

B. Cummings, T. Keane, G. Thomas, A. Harwood, and W. Rider, Results and toxicity of the treatment of anal canal carcinoma by radiation therapy or radiation therapy and chemotherapy, Cancer, vol.54, issue.10, p.20628, 1984.

G. Tanum, K. Tveit, K. O. Karlsen, and M. Hauer-jensen, Chemotherapy and radiation therapy for anal carcinoma. Survival and late morbidity, Cancer. 15 mai, vol.67, issue.10, p.24626, 1991.

E. Touboul, M. Schlienger, L. Buffat, D. Lefkopoulos, F. Pène et al., Epidermoid carcinoma of the anal canal. Results of curative-intent radiation therapy in a series of 270 patients, Cancer. 15 mars, vol.73, issue.6, p.156979, 1994.

J. Martenson, S. Lipsitz, H. Wagner, E. Kaplan, L. Otteman et al., Initial results of a phase II trial of high dose radiation therapy, 5-fluorouracil, and cisplatin for patients with anal cancer (E4292): An eastern cooperative oncology group study, Int J Radiat Oncol. 1 juill, vol.35, issue.4, p.7459, 1996.

H. Bartelink, F. Roelofsen, F. Eschwege, P. Rougier, J. F. Bosset et al., Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups, J Clin Oncol, vol.15, issue.5, pp.2040-2049, 1997.

A. Allal, J. M. Kurtz, G. Pipard, M. C. Marti, R. Miralbell et al., Chemoradiotherapy versus radiotherapy alone for anal cancer: a retrospective comparison, Int J Radiat Oncol Biol Phys. 1 sept, vol.27, issue.1, p.5966, 1993.

B. J. Cummings, T. J. Keane, B. O'sullivan, C. S. Wong, and C. N. Catton, Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C, Int J Radiat Oncol Biol Phys, vol.21, issue.5, p.111525, 1991.

, Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research, Lancet Lond Engl, vol.348, issue.9034, p.104954, 1996.

J. Northover, R. Glynne-jones, D. Sebag-montefiore, J. R. Meadows, H. Wan et al.,

, Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I), Br J Cancer. 30 mars, vol.102, issue.7, p.11238, 2010.

M. Flam, M. John, T. F. Pajak, N. Petrelli, R. Myerson et al., Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study, J Clin Oncol, vol.14, issue.9, pp.2527-2539, 1996.

L. L. Gunderson, K. A. Winter, J. A. Ajani, J. E. Pedersen, J. Moughan et al., Long-Term Update of US GI Intergroup RTOG 98-11 Phase III Trial for Anal Carcinoma: Survival, Relapse, and Colostomy Failure With Concurrent Chemoradiation Involving Fluorouracil/Mitomycin Versus Fluorouracil/Cisplatin, J Clin Oncol. 10 déc, vol.30, issue.35, p.434451, 2012.

R. D. James, R. Glynne-jones, H. M. Meadows, D. Cunningham, A. S. Myint et al.,

, Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2$\times$ 2 factorial trial, Lancet Oncol, vol.14, issue.6, pp.516-524, 2013.

D. Peiffert, L. Tournier-rangeard, J. Gérard, C. Lemanski, E. François et al., Induction Chemotherapy and Dose Intensification of the Radiation Boost in Locally Advanced Anal Canal Carcinoma: Final Analysis of the Randomized UNICANCER ACCORD 03 Trial, J Clin Oncol. juin, vol.30, issue.16, p.19418, 2012.

G. T. Deans, J. J. Mcaleer, and R. A. Spence, Malignant anal tumours, Br J Surg. avr, vol.81, issue.4, p.5008, 1994.

D. P. Ryan, C. C. Compton, and R. J. Mayer, Carcinoma of the anal canal, N Engl J Med. 16 mars, vol.342, issue.11, p.792800, 2000.

H. Sato, P. Koh, and D. Bartolo, Management of anal canal cancer, Dis Colon Rectum. juin, vol.48, issue.6, p.130115, 2005.
DOI : 10.1007/s10350-004-0934-z

J. Y. Bobin, J. P. Gérard, O. Chapet, P. Romestaing, and S. Isaac, Lymphatic mapping and inguinal sentinel lymph node biopsy in anal canal cancers to avoid prophylactic inguinal irradiation, Cancer Radiother J Soc Francaise Radiother Oncol. nov, vol.7, issue.1, pp.85-90, 2003.

D. Koh, C. George, L. Temple, D. J. Collins, P. Toomey et al., Diagnostic accuracy of nodal enhancement pattern of rectal cancer at MRI enhanced with ultrasmall superparamagnetic iron oxide: findings in pathologically matched mesorectal lymph nodes, AJR Am J Roentgenol. juin, vol.194, issue.6, pp.505-513, 2010.

Y. X. Wang, S. M. Hussain, G. Krestin, B. T. Nguyen, D. L. Joon et al., Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging, Radiother Oncol J Eur Soc Ther Radiol Oncol. juin, vol.11, issue.11, p.37682, 2001.

. Winton-e-de, A. G. Heriot, M. Ng, R. J. Hicks, A. Hogg et al., The impact of 18fluorodeoxyglucose positron emission tomography on the staging, management and outcome of anal cancer, Br J Cancer. 10 mars, vol.100, issue.5, p.693700, 2009.

E. Piperkova, B. Raphael, M. Altinyay, I. Castellon, R. Libes et al., Impact of PET/CT on initial staging, restaging and treatment management of anal cancer: a clinical case with literature review, J BUON Off J Balk Union Oncol. déc, vol.11, issue.4, p.5237, 2006.

S. Tehranian, G. Treglia, D. N. Krag, V. Kakhki, S. R. Zakavi et al., Sentinel Node Mapping in Anal Canal Cancer: Systematic Review and Meta-Analysis, J Gastrointestin Liver Dis, vol.22, issue.3, p.8, 2013.

C. Hirche, S. Dresel, R. Krempien, and M. Hünerbein, Sentinel node biopsy by indocyanine green retention fluorescence detection for inguinal lymph node staging of anal cancer: preliminary experience, Ann Surg Oncol. sept, vol.17, issue.9, p.235762, 2010.

, The role of endosonography in anal cancer, Parades, 1998.

S. Goldman, U. Norming, C. Svensson, and B. Glimelius, Transanorectal ultrasonography in the staging of anal epidermoid carcinoma, Int J Colorectal Dis. août, vol.6, issue.3, p.1527, 1991.

G. Roseau, L. Palazzo, P. Colardelle, S. Chaussade, D. Couturier et al., Endoscopic ultrasonography in the staging and follow-up of epidermoid carcinoma of the anal canal, Gastrointest Endosc. août, vol.40, issue.4, p.44750, 1994.

U. Herzog, M. Boss, and H. P. Spichtin, Endoanal ultrasonography in the follow-up of anal carcinoma, Surg Endosc. oct, vol.8, issue.10, p.11869, 1994.

B. Magdeburg, M. Fried, and C. Meyenberger, Endoscopic ultrasonography in the diagnosis, staging, and follow-up of anal carcinomas, Endoscopy. juin, vol.31, issue.5, p.35964, 1999.

M. Giovannini, V. J. Bardou, R. Barclay, L. Palazzo, G. Roseau et al., Anal carcinoma: prognostic value of endorectal ultrasound (ERUS), Endoscopy, vol.33, issue.03, pp.231-236, 2001.
DOI : 10.1055/s-2001-12860

D. Tarantino and M. A. Bernstein, Endoanal ultrasound in the staging and management of squamous-cell carcinoma of the anal canal: potential implications of a new ultrasound staging system, Dis Colon Rectum. janv, vol.45, issue.1, p.1622, 2002.

A. F. Christensen, M. B. Nielsen, S. A. Engelholm, H. Roed, L. B. Svendsen et al., Threedimensional anal endosonography may improve staging of anal cancer compared with twodimensional endosonography, Dis Colon Rectum. mars, vol.47, issue.3, p.3415, 2004.

M. Giovannini, J. F. Seitz, G. Houvenaeghel, J. R. Delpero, R. Rosello et al.,

, Presse Medicale Paris Fr 1983. 23 sept, vol.18, p.143940, 1989.

M. W. Stearns, C. Urmacher, S. S. Sternberg, J. Woodruff, and F. Attiyeh, Cancer of the anal canal, Curr Probl Cancer. juin, vol.4, issue.12, p.144, 1980.

S. Goldman, B. Glimelius, U. Norming, L. Påhlman, and U. Seligson, Transanorectal ultrasonography in anal carcinoma. A prospective study of 21 patients, Acta Radiol Stockh Swed, vol.29, issue.3, p.33741, 1987.
DOI : 10.1177/028418518802900315

D. S. Wade, L. Herrera, N. B. Castillo, and N. J. Petrelli, Metastases to the lymph nodes in epidermoid carcinoma of the anal canal studied by a clearing technique, Surg Gynecol Obstet. sept, vol.169, issue.3, p.23842, 1989.

G. Péley, E. Farkas, I. Sinkovics, T. Kovács, S. Keresztes et al., Inguinal sentinel lymph node biopsy for staging anal cancer, Scand J Surg SJS Off Organ Finn Surg Soc Scand Surg Soc, vol.91, issue.4, p.3368, 2002.

R. H. Cohan, P. M. Silverman, W. M. Thompson, R. A. Halvorsen, and M. E. Baker, Computed tomography of epithelial neoplasms of the anal canal, AJR Am J Roentgenol. sept, vol.145, issue.3, p.56973, 1985.

A. Scherrer, F. Reboul, D. Martin, J. C. Dupuy, and Y. Menu, CT of malignant anal canal tumors, Radiogr Rev Publ Radiol Soc N Am Inc. mai, vol.10, issue.3, p.43353, 1990.
DOI : 10.1148/radiographics.10.3.2188307

D. R. Radin, Squamous cell carcinoma of the anus and rectum in homosexual men: CT findings, J Comput Assist Tomogr. déc, vol.18, issue.6, p.9214, 1994.

C. J. Mcmahon, N. M. Rofsky, and I. Pedrosa, Lymphatic metastases from pelvic tumors: anatomic classification, characterization, and staging, Radiology. janv, vol.254, issue.1, p.3146, 2010.

D. Prezzi, R. Mandegaran, S. Gourtsoyianni, K. Owczarczyk, A. Gaya et al., The impact of MRI sequence on tumour staging and gross tumour volume delineation in squamous cell carcinoma of the anal canal, Eur Radiol. avr, vol.28, issue.4, p.15129, 2018.

E. Rusten, B. L. Rekstad, C. Undseth, G. Al-haidari, B. Hanekamp et al., Target volume delineation of anal cancer based on magnetic resonance imaging or positron emission tomography, Radiat Oncol. déc, vol.12, issue.1, 2017.
DOI : 10.1186/s13014-017-0883-z

URL : https://ro-journal.biomedcentral.com/track/pdf/10.1186/s13014-017-0883-z

D. Kulling, D. R. Feldman, C. L. Kay, D. E. Bohning, B. J. Hoffman et al., Local staging of anal and distal colorectal tumors with the magnetic resonance endoscope, Gastrointest Endosc. févr, vol.47, issue.2, p.1728, 1998.

S. C. Roach, P. A. Hulse, F. J. Moulding, R. Wilson, and B. M. Carrington, Magnetic resonance imaging of anal cancer, Clin Radiol, vol.60, issue.10, p.11119, 2005.

C. Anderson, M. Koshy, C. Staley, N. Esiashvili, S. Ghavidel et al., PET-CT fusion in radiation management of patients with anorectal tumors, Int J Radiat Oncol Biol Phys. 1 sept, vol.69, issue.1, p.15562, 2007.

M. Krengli, M. E. Milia, L. Turri, E. Mones, M. C. Bassi et al., FDG-PET/CT imaging for staging and target volume delineation in conformal radiotherapy of anal carcinoma, Radiat Oncol Lond Engl. 6 févr, vol.5, p.10, 2010.

J. M. Pepek, C. G. Willett, and B. G. Czito, Radiation therapy advances for treatment of anal cancer, J Natl Compr Cancer Netw JNCCN. janv, vol.8, issue.1, p.1239, 2010.

N. J. Bhuva, R. Glynne-jones, L. Sonoda, W. Wong, and M. K. Harrison, To PET or not to PET? That is the question. Staging in anal cancer, Ann Oncol. 1 août, vol.23, issue.8, p.207882, 2012.

C. Caldarella, S. Annunziata, G. Treglia, R. Sadeghi, N. Ayati et al., Diagnostic Performance of Positron Emission Tomography/Computed Tomography Using Fluorine-18 Fluorodeoxyglucose in Detecting Locoregional Nodal Involvement in Patients with Anal Canal Cancer: A Systematic Review and Meta-Analysis, Sci World J, p.111, 2014.

S. E. Cotter, P. W. Grigsby, B. A. Siegel, F. Dehdashti, R. S. Malyapa et al., FDGPET/CT in the evaluation of anal carcinoma, Int J Radiat Oncol. juill, vol.65, issue.3, p.7205, 2006.

M. Mistrangelo, E. Pelosi, M. Bellò, U. Ricardi, E. Milanesi et al., Role of positron emission tomography-computed tomography in the management of anal cancer, Int J Radiat Oncol Biol Phys. 1 sept, vol.84, issue.1, p.6672, 2012.

T. G. Trautmann and J. H. Zuger, Positron Emission Tomography for Pretreatment Staging and Posttreatment Evaluation in Cancer of the Anal Canal, Mol Imaging Biol. juill, vol.7, issue.4, p.30913, 2005.

A. Mahmud, R. Poon, and D. Jonker, PET imaging in anal canal cancer: a systematic review and meta-analysis, Br J Radiol. déc, vol.90, p.20170370, 1080.
DOI : 10.1259/bjr.20170370

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047643

M. Jones, G. Hruby, M. Solomon, N. Rutherford, and J. Martin, The Role of FDG-PET in the Initial Staging and Response Assessment of Anal Cancer: A Systematic Review and Meta-analysis, Ann Surg Oncol, vol.22, issue.11, p.357481, 2015.

H. Sekhar, M. Zwahlen, S. Trelle, L. Malcomson, R. Kochhar et al., Nodal stage migration and prognosis in anal cancer: a systematic review, meta-regression, and simulation study, Lancet Oncol, vol.18, issue.10, p.134859, 2017.

R. J. Myerson, M. Garofalo, E. Naqa, I. Abrams, R. A. Das et al., Elective Clinical Target Volumes for Conformal Therapy in Anorectal Cancer: An RTOG Consensus Panel Contouring Atlas, Int J Radiat Oncol. sept, vol.72, issue.1, p.71, 2008.

F. Denis and Y. Pointreau, Site de radio-anatomie et d'aide à la délinéation (SIRIADE) : présentation et bilan à un an. Cancer/Radiothérapie, vol.14, p.25, 2010.
DOI : 10.1016/s1278-3218(10)70002-0

M. Ng, T. Leong, S. Chander, J. Chu, A. Kneebone et al., Australasian Gastrointestinal Trials Group (AGITG) Contouring Atlas and Planning Guidelines for Intensity-Modulated Radiotherapy in Anal Cancer, Int J Radiat Oncol. août, vol.83, issue.5, p.145562, 2012.

J. C. Hodges, P. Das, C. Eng, A. G. Reish, A. S. Beddar et al., Intensity-modulated radiation therapy for the treatment of squamous cell anal cancer with para-aortic nodal involvement, Int J Radiat Oncol Biol Phys, vol.75, issue.3, p.7914, 2009.

, A trial looking at higher doses of chemoradiotherapy for people with locally advanced anal cancer (PLATO ACT5). Cancer Research UK, 2017.

J. P. Gerard, O. Chapet, F. Samiei, E. Morignat, S. Isaac et al., Management of inguinal lymph node metastases in patients with carcinoma of the anal canal: experience in a series of 270 patients treated in Lyon and review of the literature, Cancer. 1 juill, vol.92, issue.1, p.7784, 2001.

C. Ortholan, M. Resbeut, J. Hannoun-levi, E. Teissier, J. Gerard et al., Anal Canal Cancer: Management of Inguinal Nodes and Benefit of Prophylactic Inguinal Irradiation (CORS-03 Study), Int J Radiat Oncol. avr, vol.82, issue.5, 2012.

J. Matthews, B. H. Burmeister, M. Borg, A. L. Capp, D. Joseph et al., T1-2 anal carcinoma requires elective inguinal radiation treatment-the results of Trans Tasman Radiation Oncology Group study TROG 99.02, Radiother Oncol J Eur Soc Ther Radiol Oncol. janv, vol.98, issue.1, p.938, 2011.

T. Zilli, U. Schick, M. Ozsahin, P. Gervaz, A. D. Roth et al., Node-negative T1-T2 anal cancer: radiotherapy alone or concomitant chemoradiotherapy?, Radiother Oncol J Eur Soc Ther Radiol Oncol. janv, vol.102, issue.1, p.627, 2012.
DOI : 10.1016/j.radonc.2011.09.015

M. D. Chuong, J. M. Freilich, S. E. Hoffe, W. Fulp, J. M. Weber et al., IntensityModulated Radiation Therapy vs. 3D Conformal Radiation Therapy for Squamous Cell Carcinoma of the Anal Canal, Gastrointest Cancer Res GCR. mars, vol.6, issue.2, p.3945, 2013.

J. G. Bazan, W. Hara, A. Hsu, P. A. Kunz, J. Ford et al., Intensity-modulated radiation therapy versus conventional radiation therapy for squamous cell carcinoma of the anal canal, Cancer. 1 août, vol.117, issue.15, p.334251, 2011.

J. A. Call, M. G. Haddock, J. F. Quevedo, D. W. Larson, and R. C. Miller, Intensity-modulated radiotherapy for squamous cell carcinoma of the anal canal: efficacy of a low daily dose to clinically negative regions, Radiat Oncol Lond Engl, vol.6, p.134, 2011.

L. A. Kachnic, H. K. Tsai, J. J. Coen, L. S. Blaszkowsky, K. Hartshorn et al., Dose-painted intensity-modulated radiation therapy for anal cancer: a multi-institutional report of acute toxicity and response to therapy, Int J Radiat Oncol Biol Phys. 1 janv, vol.82, issue.1, p.1538, 2012.

M. D. Chuong, S. E. Hoffe, J. Weber, J. M. Freilich, H. Lomas et al., Outcomes of anal cancer treated with definitive IMRT-based chemoradiation, J Radiat Oncol. juin, vol.1, issue.2, p.16572, 2012.

A. B. Chakravarthy, P. J. Catalano, J. A. Martenson, J. K. Mondschein, H. Wagner et al., Long-Term Follow-Up of a Phase II Trial of High-Dose Radiation With Concurrent 5-Fluorouracil and Cisplatin in Patients With Anal Cancer (ECOG E4292), Int J Radiat Oncol, vol.81, issue.4, p.60713, 2011.

R. Doci, R. Zucali, L. Monica, G. Meroni, E. Kenda et al., Primary chemoradiation therapy with fluorouracil and cisplatin for cancer of the anus: results in 35 consecutive patients, J Clin Oncol. déc, vol.14, issue.12, p.31215, 1996.

. Ajani, M. Fluorouracil, and R. Fluorouracil, Cisplatin, and Radiotherapy for Carcinoma of the Anal Canal, JAMA, vol.299, issue.16, pp.1914-1921, 2008.

L. Capelli, C. Gardini, A. Scarpi, E. Frassineti, G. L. Saragoni et al., No evidence of NRAS mutation in squamous cell anal carcinoma (SCAC). Sci Rep, vol.25, p.37621, 2016.

C. Gardini, A. Capelli, L. Ulivi, P. Giannini, M. Freier et al., BRAF and PIK3CA status in squamous cell anal carcinoma (SCAC), PloS One, vol.9, issue.3, p.92071, 2014.

M. G. Zampino, E. Magni, A. Sonzogni, and G. Renne, K-ras status in squamous cell anal carcinoma (SCC): it's time for target-oriented treatment?, Cancer Chemother Pharmacol. déc, vol.65, issue.1, p.1979, 2009.

W. Cacheux, E. Rouleau, A. Briaux, P. Tsantoulis, P. Mariani et al., Mutational analysis of anal cancers demonstrates frequent PIK3CA mutations associated with poor outcome after salvage abdominoperineal resection, Br J Cancer, vol.14, issue.12, p.138794, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01478384

J. Mendelsohn and J. Baselga, The EGF receptor family as targets for cancer therapy, Oncogene. 27 déc, vol.19, issue.56, p.655065, 2000.

L. O. Olivatto, F. M. Vieira, B. V. Pereira, A. P. Victorino, M. Bezerra et al., Phase 1 study of cetuximab in combination with 5-fluorouracil, cisplatin, and radiotherapy in patients with locally advanced anal canal carcinoma, Cancer. 15 août, vol.119, issue.16, p.297380, 2013.

E. Deutsch, C. Lemanski, J. P. Pignon, A. Levy, A. Delarochefordiere et al., Unexpected toxicity of cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: results of the UNICANCER ACCORD 16 phase II trial, Ann Oncol Off J Eur Soc Med Oncol. nov, vol.24, issue.11, p.28348, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01798389

A. Levy, D. Azria, J. Pignon, A. Delarochefordiere, I. Martel-lafay et al., Low response rate after cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: long-term results of the UNICANCER ACCORD 16 phase II trial, Radiother Oncol J Eur Soc Ther Radiol Oncol. mars, vol.114, issue.3, p.4156, 2015.

C. M. Jones, R. Adams, A. Downing, R. Glynne-jones, M. Harrison et al., Tolerability, and Compliance of Concurrent Capecitabine or 5-Fluorouracil in Radical Management of Anal Cancer With Single-dose Mitomycin-C and Intensity Modulated Radiation Therapy: Evaluation of a National Cohort, Int J Radiat Oncol Biol Phys. 1 août, vol.101, issue.5, p.120211, 2018.

O. Matzinger, F. Roelofsen, L. Mineur, S. Koswig, E. M. Van-der-steen-banasik et al., Mitomycin C with continuous fluorouracil or with cisplatin in combination with radiotherapy for locally advanced anal cancer (European Organisation for Research and Treatment of Cancer phase II study 22011-40014), Eur J Cancer Oxf Engl, vol.45, issue.16, p.278291, 1990.
URL : https://hal.archives-ouvertes.fr/hal-00485139

W. B. Gabriel, Squamous-cell Carcinoma of the Anus and Anal Canal: An Analysis of 55 Cases, Proc R Soc Med. janv, vol.34, issue.3, p.13960, 1941.

J. E. Dalby and R. S. Pointon, The treatment of anal carcinoma by interstitial irradiation, Am J Roentgenol Radium Ther Nucl Med. mars, vol.85, p.51520, 1961.

K. Saarilahti, P. Arponen, L. Vaalavirta, and M. Tenhunen, The effect of intensity-modulated radiotherapy and high dose rate brachytherapy on acute and late radiotherapy-related adverse events following chemoradiotherapy of anal cancer, Radiother Oncol J Eur Soc Ther Radiol Oncol. juin, vol.87, issue.3, p.38390, 2008.

C. Oehler-jänne, B. Seifert, U. M. Lütolf, G. Studer, C. Glanzmann et al., Clinical outcome after treatment with a brachytherapy boost versus external beam boost for anal carcinoma, Brachytherapy. 1 juill, vol.6, issue.3, p.21826, 2007.

L. Moureau-zabotto, C. Ortholan, J. Hannoun-levi, E. Teissier, D. Cowen et al., Role of Brachytherapy in the Boost Management of Anal Carcinoma With Node Involvement (CORS03 Study), Int J Radiat Oncol. mars, vol.85, issue.3, p.13542, 2013.

A. De-la-rochefordière, A. Labib, C. Dauphinot, C. Chira, M. Campitelli et al., Radiothérapie des cancers du canal anal, Cancéro Dig, issue.4, 2011.

A. B. Benson, A. P. Venook, A. -. Hawary, M. M. Cederquist, L. Chen et al., Anal Carcinoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology, J Natl Compr Cancer Netw JNCCN. juill, vol.16, issue.7, p.85271, 2018.

D. Peiffert, G. Créhange, V. Vendrely, A. Baumann, J. Faivre et al., Radiotherapy for anal canal cancers, Cancer Radiother J Soc Francaise Radiother Oncol. sept, vol.20, pp.183-188, 2016.

D. Goéré, S. Bonnet, M. Pocard, E. Deutsch, P. Lasser et al., Oncologic and functional results after abdominoperineal resection plus pseudocontinent perineal colostomy for epidermoid carcinoma of the anus, Dis Colon Rectum. mai, vol.52, issue.5, p.95863, 2009.

D. Meulendijks, L. Dewit, N. B. Tomasoa, H. Van-tinteren, J. H. Beijnen et al., Chemoradiotherapy with capecitabine for locally advanced anal carcinoma: an alternative treatment option, Br J Cancer, vol.111, issue.9, p.172633, 2014.

G. Meadows, H. Wan, S. Gollins, S. Leslie, M. Levine et al., EXTRA-A Multicenter Phase II Study of Chemoradiation Using a 5 Day per Week Oral Regimen of Capecitabine and Intravenous Mitomycin C in Anal Cancer, Int J Radiat Oncol. sept, vol.72, issue.1, p.11926, 2008.

C. Faivre, P. Rougier, M. Ducreux, E. Mitry, A. Lusinchi et al., 5-fluorouracile and cisplatinum combination chemotherapy for metastatic squamous-cell anal cancer, Bull Cancer, vol.86, issue.10, p.8615, 1999.

S. Kim, M. Jary, T. André, V. Vendrely, B. Buecher et al., Cisplatin, and 5-fluorouracil (DCF) chemotherapy in the treatment of metastatic or unresectable locally recurrent anal squamous cell carcinoma: a phase II study of French interdisciplinary GERCOR and FFCD groups (Epitopes-HPV02 study), BMC Cancer. 25 août, vol.17, issue.1, p.574, 2017.

S. Kim, M. Jary, L. Mansi, B. Benzidane, A. Cazorla et al., DCF (docetaxel, cisplatin and 5-fluorouracil) chemotherapy is a promising treatment for recurrent advanced squamous cell anal carcinoma, Ann Oncol Off J Eur Soc Med Oncol. déc, vol.24, issue.12, p.304550, 2013.

, Collège National des Gynécologues et Obstétriciens Français, J Gynécologie Obstétrique Biol Reprod. sept, vol.34, issue.5, p.513, 2005.

A. Mervoyer, A. Lisbonna, E. Rio, and M. Mahé, Évaluation de la dose reçue par les organes à risque, Cancer/Radiothérapie. juill, vol.14, issue.45, p.2325, 2010.

C. Lafond, F. Jouyaux, J. Bellec, O. Henry, M. Perdrieux et al., Quelle RCMI ? Du « step and shoot » au VMAT : point de vue du physicien. Cancer/Radiothérapie, vol.14, p.53949, 2010.

G. Lim and F. , Anal cancer: an examination of radiotherapy strategies, Int J Radiat Oncol Biol Phys. 1 avr, vol.79, issue.5, p.1290301, 2011.

M. John, T. Pajak, M. Flam, J. Hoffman, A. Markoe et al., Dose escalation in chemoradiation for anal cancer: preliminary results of RTOG 92-08, Cancer J Sci Am. août, vol.2, issue.4, p.20511, 1996.

B. G. Czito and J. Meyer, Radiation therapy in anal and rectal cancer, Surg Oncol Clin N Am. juill, vol.22, issue.3, p.52543, 2013.

A. G. Bentzen, L. Balteskard, E. H. Wanderås, G. Frykholm, T. Wilsgaard et al., Impaired health-related quality of life after chemoradiotherapy for anal cancer: late effects in a national cohort of 128 survivors, Acta Oncol Stockh Swed. mai, vol.52, issue.4, p.73644, 2013.

K. Fakhrian, T. Sauer, A. Dinkel, S. Klemm, T. Schuster et al., Chronic adverse events and quality of life after radiochemotherapy in anal cancer patients. A single institution experience and review of the literature, Strahlenther Onkol Organ Dtsch Rontgengesellschaft Al. juin, vol.189, issue.6, p.48694, 2013.

J. J. Meyer, C. G. Willett, and B. G. Czito, Emerging role of intensity-modulated radiation therapy in anorectal cancer, Expert Rev Anticancer Ther. avr, vol.8, issue.4, p.58593, 2008.

T. M. Zagar, C. G. Willett, and B. G. Czito, Intensity-modulated radiation therapy for anal cancer: toxicity versus outcomes, Oncol Williston Park N. août, vol.24, issue.9, p.828, 2010.

M. T. Milano, A. B. Jani, K. J. Farrey, C. Rash, R. Heimann et al., Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcome, Int J Radiat Oncol Biol Phys, vol.63, issue.2, p.35461, 2005.

J. K. Salama, L. K. Mell, D. A. Schomas, R. C. Miller, K. Devisetty et al., Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience, J Clin Oncol Off J Am Soc Clin Oncol, vol.25, issue.29, p.45816, 2007.

J. M. Pepek, C. G. Willett, Q. J. Wu, S. Yoo, R. W. Clough et al., Intensity-modulated radiation therapy for anal malignancies: a preliminary toxicity and disease outcomes analysis, Int J Radiat Oncol Biol Phys. 1 déc, vol.78, issue.5, p.14139, 2010.

S. G. Defoe, S. Beriwal, H. Jones, S. Rakfal, D. E. Heron et al., Concurrent chemotherapy and intensity-modulated radiation therapy for anal carcinoma-clinical outcomes in a large National Cancer Institute-designated integrated cancer centre network, Clin Oncol R Coll Radiol G B. août, vol.24, issue.6, p.42431, 2012.

S. Vieillot, P. Fenoglietto, C. Lemanski, C. L. Moscardo, S. Gourgou et al., IMRT for locally advanced anal cancer: clinical experience of the Montpellier Cancer Center, Radiat Oncol Lond Engl. 23 mars, vol.7, p.45, 2012.

M. P. Mitchell, M. Abboud, C. Eng, A. S. Beddar, S. Krishnan et al., Intensitymodulated radiation therapy with concurrent chemotherapy for anal cancer: outcomes and toxicity, Am J Clin Oncol, vol.37, issue.5, p.4616, 2014.

L. A. Kachnic, K. Winter, R. J. Myerson, M. D. Goodyear, J. Willins et al., RTOG 0529: A Phase 2 Evaluation of Dose-Painted Intensity Modulated Radiation Therapy in Combination With 5-Fluorouracil and Mitomycin-C for the Reduction of Acute Morbidity in Carcinoma of the Anal Canal, Int J Radiat Oncol. mai, vol.86, issue.1, p.2733, 2013.

J. M. Herman and C. R. Thomas, RTOG 0529: Intensity modulated radiation therapy and anal cancer, a step in the right direction?, Int J Radiat Oncol Biol Phys. 1 mai, vol.86, issue.1, p.810, 2013.

J. E. Meyer, V. Panico, H. Marconato, D. L. Sherr, C. P. Pirog et al., HIV positivity but not HPV/p16 status is associated with higher recurrence rate in anal cancer, J Gastrointest Cancer. déc, vol.44, issue.4, p.4505, 2013.

L. Cunin, M. Alfa-wali, J. Turner, M. Bower, L. Ion et al., Salvage surgery for residual primary and locally recurrent anal squamous cell carcinoma after chemoradiotherapy in HIVpositive individuals, Ann Surg Oncol. févr, vol.21, issue.2, p.52732, 2014.

S. Johansen, M. H. Norman, E. Dale, C. D. Amdal, T. Furre et al., Patterns of localregional recurrence after conformal and intensity-modulated radiotherapy for head and neck cancer, Radiat Oncol. déc, vol.12, issue.1, 2017.

W. T. Ng, M. Lee, W. M. Hung, C. W. Choi, K. C. Lee et al., Clinical outcomes and patterns of failure after intensity-modulated radiotherapy for nasopharyngeal carcinoma, Int J Radiat Oncol Biol Phys. 1 févr, vol.79, issue.2, p.4208, 2011.

N. Hodapp, prescribing, recording and reporting photon-beam intensitymodulated radiation therapy, vol.83

, Strahlenther Onkol Organ Dtsch Rontgengesellschaft Al. janv, vol.188, issue.1, p.979, 2012.

R. Ferrigno, A. Santos, L. C. Martins, E. Weltman, M. J. Chen et al., Comparison of conformal and intensity modulated radiation therapy techniques for treatment of pelvic tumors. Analysis of acute toxicity, Radiat Oncol Lond Engl. 14 déc, vol.5, p.117, 2010.

K. Han, B. J. Cummings, P. Lindsay, J. Skliarenko, T. Craig et al., Prospective evaluation of acute toxicity and quality of life after IMRT and concurrent chemotherapy for anal canal and perianal cancer, Int J Radiat Oncol Biol Phys, vol.90, issue.3, p.58794, 2014.

G. Sebag-montefiore, D. Meadows, H. M. Cunningham, D. Begum, R. Adab et al., Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus (ACT II): a post-hoc analysis of randomised controlled phase 3 trial, Lancet Oncol. mars, vol.18, issue.3, p.34756, 2017.

B. Moughan, J. Ajani, J. A. Flam, M. Gunderson, L. Pollock et al., Impact of Overall Treatment Time on Survival and Local Control in Patients With Anal Cancer: A Pooled Data Analysis of Radiation Therapy Oncology Group Trials 87-04 and 98-11, J Clin Oncol. déc, vol.28, issue.34, p.50616, 2010.

R. Graf, P. Wust, B. Hildebrandt, H. Gögler, R. Ullrich et al., Impact of Overall Treatment Time on Local Control of Anal Cancer Treated with Radiochemotherapy, Oncology, vol.65, issue.1, p.1422, 2003.

R. Muirhead, M. Partridge, and M. A. Hawkins, A tumor control probability model for anal squamous cell carcinoma, Radiother Oncol. août, vol.116, issue.2, p.1926, 2015.

D. Sebag-montefiore, A. R. Bell, S. Berkman, L. Gilbert, D. C. et al., The Development of an Umbrella Trial (PLATO) to Address Radiation Therapy Dose Questions in the Locoregional Management of Squamous Cell Carcinoma of the Anus, Int J Radiat Oncol, vol.96, issue.2, p.1645, 2016.

H. Ortholan, C. Resbeut, M. Teissier, E. Ronchin, P. Cowen et al., HighDose Split-Course Radiation Therapy for Anal Cancer: Outcome Analysis Regarding the Boost Strategy (CORS-03 Study), Int J Radiat Oncol. juill, vol.80, issue.3, p.71220, 2011.

M. Mistrangelo, E. Pelosi, M. Bellò, I. Castellano, P. Cassoni et al., Comparison of Positron Emission Tomography Scanning and Sentinel Node Biopsy in the Detection of Inguinal Node Metastases in Patients With Anal Cancer, Int J Radiat Oncol. mai, vol.77, issue.1, p.738, 2010.

J. Sveistrup, A. Loft, A. K. Berthelsen, B. M. Henriksen, M. B. Nielsen et al., Positron emission tomography/computed tomography in the staging and treatment of anal cancer, Int J Radiat Oncol Biol Phys. 1 mai, vol.83, issue.1, p.13441, 2012.

C. J. Brooks, L. Bernier, V. N. Hansen, and D. M. Tait, Target volume motion during anal cancer image guided radiotherapy using cone-beam computed tomography, Br J Radiol. mai, vol.91, p.20170654, 1085.